The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly.

Eli Lilly and Co. is funding and participating in an Indiana University study that examines the health outcomes of people on ...

Prosper Junior Bakiny has positions in Eli Lilly and Viking Therapeutics. The Motley Fool recommends Viking Therapeutics. The Motley Fool has a disclosure policy. Eli Lilly holds the lead position in ...

The Only Way To Tell When a Watermelon is Ripe, According to a Farmer Destroyer USS Gravely leaves Trinidad and Tobago after ...

Both sales figures came in well ahead of analyst expectations and will heap pressure on Lilly's main rival in the GLP-1 ...

In long-awaited cuts just months after completing its $8 billion merger with Skydance, Paramount has begun layoffs set to ...

Novo Nordisk has notified employees impacted by the drugmaker's job cuts in the vast majority of its locations although the ...

Pharma major CEO Mike Doustdar, on Friday, 31 October 2025, said that the company has notified its employees who have been ...

Aging populations and clearer U.S. drug pricing boost long-term pharma outlook. Leaders like Eli Lilly and Merck lead in ...

UPS, in the throes of a cost-cutting drive, said Tuesday that it had reduced its workforce by 48,000 employees this year. The ...

On Monday, Clark, along with teammates Kelsey Mitchell and Aari McDonald, took part in a “surprise” talk for ...

Pharmaceutical company Eli Lilly and Company—or Lilly—announced its plans to build a $6.5 billion manufacturing facility at Generation Park at a news conference Sept. 23.